238 related articles for article (PubMed ID: 18473860)
1. Locked nucleic acid holds promise in the treatment of cancer.
Frieden M; Ørum H
Curr Pharm Des; 2008; 14(11):1138-42. PubMed ID: 18473860
[TBL] [Abstract][Full Text] [Related]
2. Antisense oligonucleotide-based therapeutics for cancer.
Dean NM; Bennett CF
Oncogene; 2003 Dec; 22(56):9087-96. PubMed ID: 14663487
[TBL] [Abstract][Full Text] [Related]
3. Antisense oligonucleotides: a new therapeutic approach.
Temsamani J; Guinot P
Biotechnol Appl Biochem; 1997 Oct; 26(2):65-71. PubMed ID: 9357101
[TBL] [Abstract][Full Text] [Related]
4. Nucleic acid modulation of gene expression: approaches for nucleic acid therapeutics against cancer.
Nakata Y; Kim TK; Shetzline S; Gewirtz AM
Crit Rev Eukaryot Gene Expr; 2005; 15(2):163-82. PubMed ID: 16022634
[TBL] [Abstract][Full Text] [Related]
5. Locked nucleic acid (LNA): A modern approach to cancer diagnosis and treatment.
Kamali MJ; Salehi M; Fatemi S; Moradi F; Khoshghiafeh A; Ahmadifard M
Exp Cell Res; 2023 Feb; 423(1):113442. PubMed ID: 36521777
[TBL] [Abstract][Full Text] [Related]
6. The application of locked nucleic acids in the treatment of cancer.
Frieden M; Orum H
IDrugs; 2006 Oct; 9(10):706-11. PubMed ID: 17016778
[TBL] [Abstract][Full Text] [Related]
7. Antisense oligonucleotides as therapeutics for malignant diseases.
Ho PT; Parkinson DR
Semin Oncol; 1997 Apr; 24(2):187-202. PubMed ID: 9129689
[TBL] [Abstract][Full Text] [Related]
8. Oligonucleotides as anticancer agents: from the benchside to the clinic and beyond.
Coppelli FM; Grandis JR
Curr Pharm Des; 2005; 11(22):2825-40. PubMed ID: 16101440
[TBL] [Abstract][Full Text] [Related]
9. Locked nucleic acid: a potent nucleic acid analog in therapeutics and biotechnology.
Jepsen JS; Sørensen MD; Wengel J
Oligonucleotides; 2004; 14(2):130-46. PubMed ID: 15294076
[TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotides: the state of the art.
Aboul-Fadl T
Curr Med Chem; 2005; 12(19):2193-214. PubMed ID: 16178780
[TBL] [Abstract][Full Text] [Related]
11. Technology evaluation: ISIS-2503, Isis Pharmaceuticals.
Morse MA
Curr Opin Mol Ther; 2001 Dec; 3(6):589-94. PubMed ID: 11804274
[TBL] [Abstract][Full Text] [Related]
12. G 3139. Augmerosen, Bcl-2 antisense oligonucleotide--Genta, GC 3139, Genasense.
Drugs R D; 2002; 3(1):44-9. PubMed ID: 11881530
[No Abstract] [Full Text] [Related]
13. Synthetic oligonucleotides as therapeutics: the coming of age.
Ma DD; Rede T; Naqvi NA; Cook PD
Biotechnol Annu Rev; 2000; 5():155-96. PubMed ID: 10875000
[TBL] [Abstract][Full Text] [Related]
14. Combinatorial application of nucleic acid-based agents targeting protein kinases for cancer treatment.
Spänkuch B; Strebhardt K
Curr Pharm Des; 2008; 14(11):1098-112. PubMed ID: 18473857
[TBL] [Abstract][Full Text] [Related]
15. Antisense therapeutics: from theory to clinical practice.
Pirollo KF; Rait A; Sleer LS; Chang EH
Pharmacol Ther; 2003 Jul; 99(1):55-77. PubMed ID: 12804699
[TBL] [Abstract][Full Text] [Related]
16. Antisense therapy in oncology: new hope for an old idea?
Tamm I; Dörken B; Hartmann G
Lancet; 2001 Aug; 358(9280):489-97. PubMed ID: 11513935
[TBL] [Abstract][Full Text] [Related]
17. Oligonucleotide technologies: synthesis, production, regulations and applications. 29-30th November 2000, Hamburg, Germany.
Uhlmann E
Expert Opin Biol Ther; 2001 Mar; 1(2):319-28. PubMed ID: 11727539
[TBL] [Abstract][Full Text] [Related]
18. [Antisense oligonucleotides: a new therapeutic approach].
Guinot P; Temsamani J
Pathol Biol (Paris); 1998 May; 46(5):347-54. PubMed ID: 9769897
[TBL] [Abstract][Full Text] [Related]
19. In vivo tumor growth inhibition and biodistribution studies of locked nucleic acid (LNA) antisense oligonucleotides.
Fluiter K; ten Asbroek AL; de Wissel MB; Jakobs ME; Wissenbach M; Olsson H; Olsen O; Oerum H; Baas F
Nucleic Acids Res; 2003 Feb; 31(3):953-62. PubMed ID: 12560491
[TBL] [Abstract][Full Text] [Related]
20. AEG-35156, an antisense oligonucleotide against X-linked inhibitor of apoptosis for the potential treatment of cancer.
Tamm I
Curr Opin Investig Drugs; 2008 Jun; 9(6):638-46. PubMed ID: 18516763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
